• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconMylan

Mylan

Page 2 of 6
HealthMylan’s EpiPen Competitor Is Also Under Fire for Drug Price Hikes
By Sy MukherjeeFebruary 8, 2017
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
HealthCVS Is Now Selling an EpiPen Competitor at a Massive Discount
By Sy MukherjeeJanuary 12, 2017
John Stumpf
FinanceThe 5 Biggest Corporate Scandals of 2016
By Chris Matthews and Matthew HeimerDecember 28, 2016
House Oversight Committee Holds Hearing On Rising Price Of EpiPens With Mylan Inc. CEO Heather Bresch
Health20 States Are Suing Mylan and Other Drug Companies for Allegedly Fixing Prices
By Reuters and Michelle TohDecember 16, 2016
Man walks downstairs
HealthBig Pharma Just Had a Terrible, Horrible, No Good, Very Bad Week of Job Cuts
By Sy MukherjeeDecember 12, 2016
Mylan NV EpiPen 2-Pak medication sits on a table inside a pharmacy in Provo, Utah, U.S., on Wednesday, Aug. 31, 2016.
RetailEpiPen Maker Mylan May Cut Jobs as Part of Restructuring Effort
By ReutersDecember 7, 2016
Heather Bresch
HealthMylan’s CEO Is Right—Pharma’s Price Hikes Could Ultimately Lead to Some Good
By Sy MukherjeeDecember 2, 2016
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
HealthEpiPen Maker Mylan Will Be a No-Show at Upcoming Senate Hearing
By The Associated PressNovember 21, 2016
HealthMylan Says It’s Close to Inking an EpiPen Medicaid Settlement
By ReutersNovember 10, 2016
HealthSenators Are Pushing for an Antitrust Probe of Mylan
By ReutersNovember 8, 2016
HealthFederal Prosecutors Reportedly Plan Major Price Fixing Suit Against Drug Makers
By Sy MukherjeeNovember 3, 2016
RetailThe Fortune Guide to Dressing Up for Halloween
By Christina AustinOctober 28, 2016
Key Speakers At The Bloomberg Year Ahead 2015 Conference
HealthMylan’s EpiPen Price Hikes Reportedly Add Millions to Pentagon Costs
By Reuters and Michelle TohOctober 28, 2016
House Oversight Committee Holds Hearing On Rising Price Of EpiPens With Mylan Inc. CEO Heather Bresch
HealthMylan Execs Probably Won’t Lose Any Money Over the Massive EpiPen Settlement
By Sy MukherjeeOctober 27, 2016
One analyst thinks Mylan's EpiPen price hike ties back to its executive incentive plans.
HealthMylan’s Expensive EpiPen Is About to Get Some Competition
By ReutersOctober 26, 2016
1
  • 1
  • 2
  • 3
  • 4
  • 5
6
Most Popular
Success
After decades in the music industry, Pharrell Williams admits he never stops working: ‘If you do what you love everyday, you’ll get paid for free'An image of a popular article
By Emma BurleighFebruary 3, 2026
Politics
Peter Thiel warns the Antichrist and apocalypse are linked to the ‘end of modernity’ currently happening—and cites Greta Thunberg as a driving exampleAn image of a popular article
By Nick LichtenbergFebruary 4, 2026
Investing
Ray Dalio warns the world is ‘on the brink’ of a capital war of weaponizing money—and gold is the best way for people to protect themselvesAn image of a popular article
By Sasha RogelbergFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.